Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Tarantino, Giovanni ^a   Finelli, Carmine ^b   Colao, Annamaria ^a   Capone, Domenico ^a   Tarantino, Marianna ^a   Grimaldi, Ernesto ^a   Chianese, Donato ^a   Gioia, Saverio ^b   Pasanisi, Fabrizio ^a   Contaldo, Franco ^a   Scopacasa, Francesco ^a   Savastano, Silvia ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Fondazione Stella Maris Mediterraneo   (Italy)

Author keywords

Atherosclerosis; Metabolic syndrome; NAFLD

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; FERRITIN; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; HEAT SHOCK PROTEIN 70;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APOPTOSIS; ARTERIAL WALL THICKNESS; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; FATTY LIVER; FEMALE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; CASE CONTROL STUDY; ENZYMOLOGY; FACTORIAL ANALYSIS; METABOLISM; MIDDLE AGED;

CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; FACTOR ANALYSIS, STATISTICAL; FATTY LIVER; GAMMA-GLUTAMYLTRANSFERASE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MIDDLE AGED; OBESITY;

EID: 84858174466     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-50     Document Type: Article

References (41)

1. Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol 2007, 22:293-303. 10.1111/j.1440-1746.2007.04824.x, 17295757.
2. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005, 115:1343-51. 1087172, 15864352.
3. Wei Y, Wang D, Pagliassotti MJ. Saturated fatty acid-mediated endoplasmic reticulum stress and apoptosis are augmented by trans-10, cis-12-conjugated linoleic acid in liver cells. Mol Cell Biochem 2007, 303:105-13. 10.1007/s11010-007-9461-2, 17426927.
4. Kapoor A, Sanyal AJ. Endoplasmic reticulum stress and the unfolded protein response. Clin Liver Dis 2009, 13:581-90. 10.1016/j.cld.2009.07.004, 19818306.
5. Civelek M, Manduchi E, Riley RJ, Stoeckert CJ, Davies PF. Chronic endoplasmic reticulum stress activates unfolded protein response in arterial endothelium in regions of susceptibility to atherosclerosis. Circ Res 2009, 105:453-61. 10.1161/CIRCRESAHA.109.203711, 2746924, 19661457.
6. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, et al. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-6. 10.1038/nature01137, 12447443.
7. Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 2007, 133:490-506.
8. Njemini R, Bautmans L, Onyema OO, Van Puyvelde K, Demanet C, Mets T. Circulating heat shock protein 70 in health, aging and disease. BMC Immunol 2011, 12:24. 10.1186/1471-2172-12-24, 3074541, 21443787.
9. Zhang L, Perdomo G, Kim DH, Qu S, Ringquist S, Trucco M, et al. Proteomic analysis of fructose-induced fatty liver in hamsters. Metabolism 2008, 57:1115-24. 10.1016/j.metabol.2008.03.017, 2553352, 18640390.
10. Yamagami K, Enders G, Schauer RJ, Leiderer R, Hutter J, Yamamoto Y, et al. Heat-shock preconditioning protects fatty livers in genetically obese Zucker rats from microvascular perfusion failure after ischemia reperfusion. Transpl Int 2003, 16:456-63.
11. Massip-Salcedo M, Casillas-Ramirez A, Franco-Gou R, Bartrons R, Ben Mosbah I, Serafin A, et al. Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers. Am J Pathol 2006, 168:1474-85. 10.2353/ajpath.2006.050645, 1606592, 16651615.
12. Ribas V, Nguyen MT, Henstridge DC, Nguyen AK, Beaven SW, Watt MJ, et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ER alpha-deficient mice. Am J Physiol Endocrinol Metab 2010, 298:E304-19. 10.1152/ajpendo.00504.2009, 2822483, 19920214.
13. Merchant S, Korbelik M. Heat shock protein 70 is acute phase reactant: response elicited by tumor treatment with photodynamic therapy. Cell Stress Chaperones 2010,
14. Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis?. Eur J Gastroenterol Hepatol 2009, 21:504-11. 10.1097/MEG.0b013e3283229b40, 19318968.
15. Tsan MF, Gao B. Heat shock proteins and immune system. J Leukoc Biol 2009, 85:905-10. 10.1189/jlb.0109005, 19276179.
16. Marotta F, Koike K, Lorenzetti A, Naito Y, Fayet F, Shimizu H, et al. Nutraceutical strategy in aging: targeting heat shock protein and inflammatory profile through understanding interleukin-6 polymorphism. Ann N Y Acad Sci 2007, 1119:196-202. 10.1196/annals.1404.011, 18056967.
17. André P, Balkau B, Vol S, Charles MA, Eschwège E, . DESIR Study Group Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care 2007, 30:2355-2361. 10.2337/dc07-0440, 17586745, DESIR Study Group.
18. Lee DH, Blomhoff R, Jacobs DR. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res 2004, 38:535-539. 10.1080/10715760410001694026, 15346644.
19. Freeman ML, Sierra-Rivera E, Voorhees GJ, Eisert DR, Meredith MJ. Synthesis of hsp-70 is enhanced in glutathione-depleted Hep G2 cells. Radiat Res 1993, 135:387-93. 10.2307/3578879, 8378532.
20. Haring R, Wallaschofski H, Nauck M, Dörr M, Baumeister SE, Völzke H. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 2009, 59:1403-11.
21. Meisinger C, Döring A, Schneider A, Löwel H, . KORA Study Group Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 2006, 189:297-302. 10.1016/j.atherosclerosis.2006.01.010, 16483579, KORA Study Group.
22. Magyar MT, Szikszai Z, Balla J, Valikovics A, Kappelmayer J, Imre S, et al. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 2003, 34:58-63. 10.1161/01.STR.0000048845.83285.AC, 12511751.
23. Savastano S, Di Somma C, Pizza G, De Rosa A, Nedi V, Rossi A, et al. Liver-spleen axis, Insulin-like Growth Factor-(IGF)-I axis and fat mass in overweight/obese females. J Transl Med 2011, 9:136. 10.1186/1479-5876-9-136, 3177905, 21846339.
24. Webb M, Yeshua H, Zelber-Sagi S, Santo E, Brazowski E, Halpern Z, et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol 2009, 192:909-14. 10.2214/AJR.07.4016, 19304694.
25. Chiang CH, Huang CC, Chan WL, Chen JW, Leu HB. The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population. Clin Biochem 2010, 43:1399-404. 10.1016/j.clinbiochem.2010.09.003, 20846522.
26. Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008, 49:600-7. 10.1016/j.jhep.2008.06.012, 18672311.
27. Stefan N, Kantartzis K, Häring HU. Causes and metabolic consequences of Fatty liver. Endocr Rev 2008, 29:939-60. 10.1210/er.2008-0009, 18723451.
28. McKimmie RL, Daniel KR, Carr JJ, Bowden DW, Freedman BI, Register TC, et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol 2008, 103:3029-35. 10.1111/j.1572-0241.2008.02188.x, 18853970.
29. Petit JM, Guiu B, Terriat B, Loffroy R, Robin I, Petit V, et al. Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. J Clin Endocrinol Metab 2009, 94:4103-6. 10.1210/jc.2009-0541, 19584186.
30. Kim HC, Kim DJ, Huh KB. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 2009, 204:521-5. 10.1016/j.atherosclerosis.2008.09.012, 18947828.
31. Wong VW, Wong GL, Yip GW, Lo AO, Limquiaco J, Chu WC, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 2011,
32. Wunderlich FT, Ströhle P, Könner AC, Gruber S, Tovar S, Brönneke HS, et al. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab 2010, 12:237-49. 10.1016/j.cmet.2010.06.011, 20816090.
33. Perseghin G. Viewpoints on the way to a consensus session: where does insulin resistance start? The liver. Diabetes Care 2009, 32:S164-7. 10.2337/dc09-S303, 2811471, 19875545.
34. Han S, Liang CP, Westerterp M, Senokuchi T, Welch CL, Wang Q, et al. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. J Clin Invest 2009, 119:1029-41. 2662550, 19273907.
35. Ludwig M, von Petzinger-Kruthoff A, von Buquoy M, Stumpe KO. Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint. Ultraschall Med 2003, 24:162-74.
36. Pockley AG, Calderwood SK, Multhoff G. The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions?. Cell Stress Chaperones 2009, 14:545-53. 10.1007/s12192-009-0113-1, 2866956, 19357992.
37. Assmann G, Gotto AM. HDL cholesterol and protective factors in atherosclerosis. Circulation 2004, 109:III8-14.
38. Singh SK, Sureh MV, Voleti B, Agrawal A. The connection between C-reactive protein and atherosclerosis. Annals Medicine 2008, 40:110-20.
39. Hodge AM, Dowse GK, Collins VR, Alberti KG, Gareeboo H, Tuomilehto J, Zimmet PZ. Abdominal fat distribution and insulin levels only partially explain adverse cardiovascular risk profile in Asian Indians. J Cardiovasc Risk 1996, 3:263-70. 10.1097/00043798-199606000-00001, 8863097.
40. Ghayour-Mobarhan M, Lamb DJ, Tavallaie S, Ferns GA. Relationship between plasma cholesterol, von Willebrand factor concentrations, extent of atherosclerosis and antibody titres to heat shock proteins-60, -65 and -70 in cholesterol-fed rabbits. Int J Exp Pathol 2007, 88:249-55. 10.1111/j.1365-2613.2007.00542.x, 2517311, 17696906.
41. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011, 140:124-31. 10.1053/j.gastro.2010.09.038, 20858492.